A home collection device for diabetes risk testing

Labcorp has launched a product that has the potential to make it easy for people to see if they are at risk of developing diabetes.

The Burlington, North Carolina-based company said its Labcorp OnDemand test measures hemoglobin A1c (HbA1c) from a small blood sample. The company uses a collection device from Weavr Health, a diagnostics company that provides remote biofluid collection devices to expand access to health and wellness testing.

Through a capital investment by Labcorp, the device was co-developed for HbA1c by the two companies, with Weavr remaining the owner of the device.

The device separates plasma and red blood cells, allowing for more in-depth and complex analysis of the sample. It has been designed to enclose the sample to keep it contained, safe and stable for transport and testing. After collection, the device is returned to Labcorp via a prepaid FedEx envelope.

“Diabetes is a serious disease that affects millions of people in the United States,” said Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostics. “Our Labcorp OnDemand Diabetes Risk Test home collection kit now enables consumers to better understand their diabetes risk and health status using an innovative and approved collection device. This test provides a convenient way for more people to manage their health and stay informed, so they can seek treatment that can lead to better health outcomes.

Comments are closed.